Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (107)

2026

  1. Altered placental expression of neurotransmitter and stress-related molecules in first-episode psychosis during pregnancy: Implications for cytoarchitecture and function

    Psychoneuroendocrinology, Vol. 186

  2. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  3. Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 1, pp. 58-73

  4. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  5. Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort

    HIV Medicine, Vol. 27, Núm. 4, pp. 546-559

  6. Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis

    Journal of Hepatology

  7. Multicenter, double-blind, sham endoscopy-controlled, randomized trial evaluating the efficacy of antireflux mucosal ablation for the treatment of gastroesophageal reflux disease

    Endoscopy, Vol. 58, Núm. 6, pp. 595-607

  8. Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis

    Journal of Viral Hepatitis, Vol. 33, Núm. 4

  9. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)

    Clinical Infectious Diseases, Vol. 82, Núm. 3, pp. e511-e520

2025

  1. A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    Journal of Antimicrobial Chemotherapy, Vol. 80, Núm. 12, pp. 3438-3451

  2. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  3. Clinical Perspectives on Long-Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain—The ALBA Study

    Liver International, Vol. 45, Núm. 12

  4. Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study

    Medicina (Lithuania), Vol. 61, Núm. 12

  5. Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors

    AIDS and Behavior, Vol. 29, Núm. 7, pp. 2324-2335

  6. Dysregulation of Circadian Markers, HAT1 and Associated Epigenetic Proteins, and the Anti-Aging Protein KLOTHO in Placenta of Pregnant Women with Chronic Venous Disease

    Journal of Personalized Medicine, Vol. 15, Núm. 3

  7. Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024)

    Open Forum Infectious Diseases, Vol. 12, Núm. 12

  8. Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis

    Gut, Vol. 74, Núm. 8, pp. 1293-1307

  9. Increased mortality and morbidity risk in people with early HIV care interruption in Spain

    AIDS, Vol. 39, Núm. 9, pp. 1224-1234

  10. Mechanical power is not associated with mortality in COVID-19 mechanically ventilated patients

    Annals of Intensive Care, Vol. 15, Núm. 1

  11. Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients

    Liver International, Vol. 45, Núm. 1